| scholarly article | Q13442814 |
| P50 | author | Philippe Sansonetti | Q570674 |
| Claude Parsot | Q33145690 | ||
| Andrej Weintraub | Q43286147 | ||
| Hélène D'Hauteville | Q124155507 | ||
| P2093 | author name string | Duncan J Maskell | |
| Richard J Ulevitch | |||
| John Mathison | |||
| Shahid Khan | |||
| Anders Kussak | |||
| Nicole Wuscher | |||
| P2860 | cites work | Protein measurement with the Folin phenol reagent | Q20900776 |
| A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. | Q53438021 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| Shigella flexneri | Q1644417 | ||
| P304 | page(s) | 5240-5251 | |
| P577 | publication date | 2002-05-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Two msbB genes encoding maximal acylation of lipid A are required for invasive Shigella flexneri to mediate inflammatory rupture and destruction of the intestinal epithelium | |
| P478 | volume | 168 |
| Q44118567 | A novel caspase-1/toll-like receptor 4-independent pathway of cell death induced by cytosolic Shigella in infected macrophages |
| Q36131717 | A specific role for TLR1 in protective T(H)17 immunity during mucosal infection |
| Q38284501 | An assessment of enterotoxigenic Escherichia coli and Shigella vaccine candidates for infants and children |
| Q35548977 | An msbB homologue carried in plasmid pO157 encodes an acyltransferase involved in lipid A biosynthesis in Escherichia coli O157:H7. |
| Q34941041 | Analysis of virulence and inflammatory potential of Shigella flexneri purine biosynthesis mutants |
| Q73555512 | Anti-inflammatory role for intracellular dimeric immunoglobulin a by neutralization of lipopolysaccharide in epithelial cells |
| Q34983841 | Bacterial strategies for overcoming host innate and adaptive immune responses |
| Q35796146 | Bioimage analysis of Shigella infection reveals targeting of colonic crypts |
| Q34394744 | Characterization of WRSs2 and WRSs3, new second-generation virG(icsA)-based Shigella sonnei vaccine candidates with the potential for reduced reactogenicity |
| Q36430606 | Characterization of htrB and msbB mutants of the light organ symbiont Vibrio fischeri |
| Q34357463 | Characterization of lipid A profiles from Shigella flexneri variant X lipopolysaccharide |
| Q44904840 | Chromosomal and plasmid-encoded enzymes are required for assembly of the R3-type core oligosaccharide in the lipopolysaccharide of Escherichia coli O157:H7. |
| Q36844719 | Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road |
| Q34200649 | Common changes in global gene expression induced by RNA polymerase inhibitors in Shigella flexneri |
| Q92351722 | Contrasting evolution of virulence and replication rate in an emerging bacterial pathogen |
| Q36080839 | Design of a covalently linked human interleukin-10 fusion protein and its secretory expression in Escherichia coli |
| Q37337410 | Differential activation of human TLR4 by Escherichia coli and Shigella flexneri 2a lipopolysaccharide: combined effects of lipid A acylation state and TLR4 polymorphisms on signaling |
| Q38608685 | Differential regulation by magnesium of the two MsbB paralogs of Shigella flexneri. |
| Q34599513 | Discovery of new biosynthetic pathways: the lipid A story. |
| Q37980947 | Diverse microbial interactions with the basement membrane barrier |
| Q37638547 | Evaluation of an intragastric challenge model for Shigella dysenteriae 1 in rhesus monkeys (Macaca mulatta) for the pre-clinical assessment of Shigella vaccine formulations |
| Q44445061 | Experimental evidence for distinct costs of pathogenesis and immunity against a natural pathogen in a wild bird |
| Q104461966 | Experimental evidence for stabilizing selection on virulence in a bacterial pathogen |
| Q28078180 | Gut microbiota and immune crosstalk in metabolic disease |
| Q40145683 | Gut microbiota and immune crosstalk in metabolic disease |
| Q37548187 | Hexa-acylated lipid A is required for host inflammatory response to Neisseria gonorrhoeae in experimental gonorrhea |
| Q40197132 | Hierarchical gene expression profiles of HUVEC stimulated by different lipid A structures obtained from Porphyromonas gingivalis and Escherichia coli |
| Q28728768 | High yield production process for Shigella outer membrane particles |
| Q35098571 | Human colonic myocytes are involved in postischemic inflammation through ADAM17-dependent TNFalpha production |
| Q40157199 | Identification and Characterization of Two Klebsiella pneumoniae lpxL Lipid A Late Acyltransferases and Their Role in Virulence |
| Q38408340 | Immune responses of wild birds to emerging infectious diseases |
| Q40460000 | Immunogenicity and characterization of WRSF2G11: a second generation live attenuated Shigella flexneri 2a vaccine strain. |
| Q37602699 | Immunomodulation using genetically engineered bacteria for type III-mediated delivery of heterologous antigens and cytokines: potential application in vaccine and therapeutical developments |
| Q37319790 | Intracellular Shigella remodels its LPS to dampen the innate immune recognition and evade inflammasome activation. |
| Q33769305 | Involvement of the Escherichia coli O157:H7(pO157) ecf operon and lipid A myristoyl transferase activity in bacterial survival in the bovine gastrointestinal tract and bacterial persistence in farm water troughs |
| Q34298699 | LcrV delivered via type III secretion system of live attenuated Yersinia pseudotuberculosis enhances immunogenicity against pneumonic plague |
| Q24650951 | Lipid A modification systems in gram-negative bacteria |
| Q42563797 | Modulation of Shigella virulence in response to available oxygen in vivo |
| Q34138990 | Modulation of endotoxicity of Shigella generalized modules for membrane antigens (GMMA) by genetic lipid A modifications: relative activation of TLR4 and TLR2 pathways in different mutants |
| Q33797653 | Murein lipoprotein is a critical outer membrane component involved in Salmonella enterica serovar typhimurium systemic infection |
| Q36470741 | New perspectives for a new century: implications of pathogen responses for the future of antimicrobial therapy |
| Q36138907 | Norharmane Matrix Enhances Detection of Endotoxin by MALDI-MS for Simultaneous Profiling of Pathogen, Host, and Vector Systems |
| Q87281013 | Oral administration of live Shigella vaccine candidates in rhesus monkeys show no evidence of competition for colonization and immunogenicity between different serotypes |
| Q37222618 | PagP activation in the outer membrane triggers R3 core oligosaccharide truncation in the cytoplasm of Escherichia coli O157:H7. |
| Q54341932 | Periplasmic delivery of biologically active human interleukin-10 in Escherichia coli via a sec-dependent signal peptide. |
| Q34394184 | Pleiotropic effects of the lpxM mutation in Yersinia pestis resulting in modification of the biosynthesis of major immunoreactive antigens. |
| Q39739730 | Polymyxin B resistance in El Tor Vibrio cholerae requires lipid acylation catalyzed by MsbB. |
| Q36404749 | Protective and destructive immunity in the periodontium: Part 1--innate and humoral immunity and the periodontium |
| Q35183286 | RNA-seq analysis of the influence of anaerobiosis and FNR on Shigella flexneri |
| Q38081375 | Recognition of lipid A variants by the TLR4-MD-2 receptor complex |
| Q60911592 | Role of a fluid-phase PRR in fighting an intracellular pathogen: PTX3 in Shigella infection |
| Q40755880 | Role of lipid A acylation in Yersinia enterocolitica virulence |
| Q38294092 | Safety and colonization of two novel VirG(IcsA)-based live Shigella sonnei vaccine strains in rhesus macaques (Macaca mulatta) |
| Q30369367 | Safety and immunogenicity of WRSd1, a live attenuated Shigella dysenteriae type 1 vaccine candidate. |
| Q36375529 | Salmonella enterica Serovar Typhimurium Expressing Mutant Lipid A with Decreased Endotoxicity Causes Maturation of Murine Dendritic Cells |
| Q37222605 | Secondary acylation of Klebsiella pneumoniae lipopolysaccharide contributes to sensitivity to antibacterial peptides |
| Q35007984 | Secretory expression of biologically active human Herpes virus interleukin-10 analogues in Escherichia coli via a modified Sec-dependent transporter construct |
| Q36421502 | Sensing gram-negative bacterial lipopolysaccharides: a human disease determinant? |
| Q33250412 | Shield as signal: lipopolysaccharides and the evolution of immunity to gram-negative bacteria |
| Q36267084 | Shigella spp. and enteroinvasive Escherichia coli pathogenicity factors |
| Q36703588 | Shigella's ways of manipulating the host intestinal innate and adaptive immune system: a tool box for survival? |
| Q27687005 | Shigella: a model of virulence regulation in vivo |
| Q34156236 | Species-specific activation of TLR4 by hypoacylated endotoxins governed by residues 82 and 122 of MD-2 |
| Q27728135 | Structure-guided enzymology of the lipid A acyltransferase LpxM reveals a dual activity mechanism |
| Q33925353 | Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection |
| Q34048081 | The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes |
| Q52952279 | The invasive phenotype of Shigella flexneri directs a distinct gene expression pattern in the human intestinal epithelial cell line Caco-2. |
| Q44751593 | Thermoregulation of the Escherichia coli O157:H7 pO157 ecf operon and lipid A myristoyl transferase activity involves intrinsically curved DNA. |
| Q38332702 | Transcriptional adaptation of Shigella flexneri during infection of macrophages and epithelial cells: insights into the strategies of a cytosolic bacterial pathogen |
| Q38130518 | Tumor-colonizing bacteria: a potential tumor targeting therapy |
| Q46354821 | Two live attenuated Shigella flexneri 2a strains WRSf2G12 and WRSf2G15: a new combination of gene deletions for 2nd generation live attenuated vaccine candidates |
| Q35887055 | Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni. |
| Q47548068 | Virulence and Stress Responses of Shigella flexneri Regulated by PhoP/PhoQ. |
| Q33557800 | Virulence, inflammatory potential, and adaptive immunity induced by Shigella flexneri msbB mutants |
| Q33274199 | Yeast functional genomic screens lead to identification of a role for a bacterial effector in innate immunity regulation |
Search more.